Cimzia and Poor quality sleep - a phase IV clinical study of FDA data

Summary:

Poor quality sleep is reported as a side effect among people who take Cimzia (certolizumab pegol), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Vitamin D, and have Psoriatic arthropathy.

The phase IV clinical study analyzes which people have Poor quality sleep when taking Cimzia. It is created by eHealthMe based on reports of 106,367 people who have side effects when taking Cimzia from the FDA, and is updated regularly.

What is Cimzia?

Cimzia has active ingredients of certolizumab pegol. It is often used in rheumatoid arthritis. eHealthMe is studying from 106,745 Cimzia users. Check the latest studies of Cimzia.

What is Poor quality sleep?

Poor quality sleep is found to be associated with 1,257 drugs and 1,167 conditions by eHealthMe. Check the latest studies of Poor quality sleep.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 26, 2026

106,367 people reported to have side effects when taking Cimzia.
Among them, 74 people (0.07%) have Poor quality sleep.

Among these 74 people:

How long have people been on Cimzia when they have Poor quality sleep? *

What is the gender of people who have Poor quality sleep when taking Cimzia? *

female: 79.45 %
male: 20.55 %

What is the age of people who have Poor quality sleep when taking Cimzia? *

What are other drugs people take besides Cimzia? *

What are other side effects people have besides Poor quality sleep? *

Fatigue (feeling of tiredness): 28 people, 37.84%
Diarrhea: 19 people, 25.68%
Cough: 18 people, 24.32%
Joint Pain: 16 people, 21.62%
Oropharyngeal Pain: 15 people, 20.27%
Headache (pain in head): 14 people, 18.92%
Musculoskeletal Stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves): 13 people, 17.57%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 13 people, 17.57%
Drug Ineffective: 12 people, 16.22%
Pain In Extremity: 12 people, 16.22%

What are the existing conditions these people have? *

Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 25 people, 33.78%
Dyspnea (difficult or laboured breathing): 8 people, 10.81%
Asthma: 8 people, 10.81%
Pulmonary Embolism (blockage of the main artery of the lung): 4 people, 5.41%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 4 people, 5.41%
Psoriasis (immune-mediated disease that affects the skin): 3 people, 4.05%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 2 people, 2.70%
High Blood Pressure: 2 people, 2.70%
Bone Disorder: 2 people, 2.70%
Low Density Lipoprotein Increased (cholesterol increased in blood): 1 person, 1.35%

* Approximation only. Some reports may have incomplete information.

Do you take Cimzia and have Poor quality sleep?

- Check whether Poor quality sleep is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cimzia:

Cimzia (106,745 reports)

Browse all side effects of Cimzia:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Poor quality sleep:

Poor quality sleep (1,257 drugs)

Browse all the conditions that are associated with Poor quality sleep:

Poor quality sleep (1,167 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on certolizumab pegol (the active ingredients of Cimzia) and Cimzia (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.